Sputnik V uses two different viruses that cause the common cold (adenovirus) in humans. The two doses, given 21 days apart, are different a...

Fortis Healthcare, which had said it would make Sputnik V available at its Gurgaon and Mohali hospitals from Saturday, also has not started...

Taking to Twitter, the official handle of the Russian vaccine affirmed that Sputnik V's efficacy is better on the Delta variant than any ot...

Malta-headquartered Pharma Regulatory Services Limited has given an expression of interest to the state-run HMSCL to provide doses of Sputn...

"This pilot phase will allow Dr. Reddy's and Apollo to test the arrangements and cold chain logistics and prepare for the launch. We are co...

Dr Reddy’s Laboratories has a tie-up with the Russian Direct Investment Fund, which backed the development of Sputnik V, and will import th...

The company, which transferred its vaccine technology to Serum Institute of India for distribution in India and middle-income countries, is...

Russia has already approved two COVID-19 vaccines, including the Sputnik V shot, developed by Moscow's Gamaleya Institute, following a simi...

Addressing a press briefing, Union Health Secretary Rajesh Bhushan said Zydus Cadila, Sputnik V, Biological E and Gennova are other vaccine...

The calculations were based on preliminary data obtained 42 days after the first dose, Russia's health ministry, the state-run Gamaleya res...

"Translating pharma lingo: the announced price of Pfizer of USD 19.50 and Moderna of USD 25-USD 37 per dose actually means their price of U...

Putin also proposed that the creation of a vaccine research centre for BRICS countries - Brazil, Russia, India, China and South Africa - be...

Chairman of Dr Reddys Laboratories, Satish Reddy said, "We are pleased with the collaboration with BIRAC as an advisory partner for clinica...

The Hyderabad-based pharmaceutical firm had on October 13 reapplied to the Drugs Controller General of India (DCGI) seeking permission to c...

The Indian pharma giant has collaborated with The Russian Direct Investment Fund (RDIF) to conduct clinical trials of Sputnik V as well as ...

Results from early-phase non-randomised vaccine trials in a total of 76 people show that two formulations of the vaccine have a good safety...

"The vaccine developed by the Gamaleya centre will be registered on August 12. At the moment, the last, third, stage is underway. The trial...